Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Non Operating Interest Expenses (2024 - 2025)

Updated

Niki BioSolutions' Non Operating Interest Expenses came in at -$57,157 for FY2025.

Analysis

Niki BioSolutions (NIKI) Non Operating Interest Expenses (2024 - 2025) Analysis & Trends

Going back to FY2022, Niki BioSolutions' Non Operating Interest Expenses data covers 4 years.

  • The FY2025 figure represents the highest annual Non Operating Interest Expenses since FY2022.
  • Per Business Quant, earlier years put Non Operating Interest Expenses at -$146,924 in FY2024, -$121,145 in FY2023 and $146,588 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Niki BioSolutions 2.65 Mn 2.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -27,345.00
Nov 30, 2024 -18,673.00
Aug 31, 2024 -20,166.00
API Access

Niki BioSolutions Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NIKI&period=max&api_key=YOUR_API_KEY